{"organizations": [], "uuid": "c2275abf30446b2b7e7a6fc6ae34fab888648c9d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/boston-scient-results/medical-device-maker-boston-scientific-posts-10-pct-rise-in-sales-idUSL3N1S2455", "country": "US", "domain_rank": 408, "title": "Medical device maker Boston Scientific posts 10 pct rise in sales", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T13:36:00.000+03:00", "replies_count": 0, "uuid": "c2275abf30446b2b7e7a6fc6ae34fab888648c9d"}, "author": "", "url": "https://www.reuters.com/article/boston-scient-results/medical-device-maker-boston-scientific-posts-10-pct-rise-in-sales-idUSL3N1S2455", "ord_in_thread": 0, "title": "Medical device maker Boston Scientific posts 10 pct rise in sales", "locations": [], "entities": {"persons": [{"name": "reu", "sentiment": "negative"}, {"name": "tamara mathias", "sentiment": "none"}, {"name": "shailesh kuber", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "boston scientific", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "boston scientific corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - U.S. medical device maker Boston Scientific Corp reported a 10 percent rise in first-quarter net sales on Wednesday, helped by higher demand for its products, including pacemakers and heart valves.\nNet sales rose to $2.38 billion from $2.16 billion.\nThe company posted a net profit of $298 million, or 21 cents per share, in the quarter ended March 31, versus $290 million, or 21 cents per share, a year earlier. (Reporting by Tamara Mathias in Bengaluru; Editing by Shailesh Kuber)\n ", "external_links": [], "published": "2018-04-25T13:36:00.000+03:00", "crawled": "2018-04-25T13:52:41.017+03:00", "highlightTitle": ""}